| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institute of Molecular and Cellular Biosciences (D.C., A.M.)
The University of Tokyo Tokyo 113-0032, Japan.
The Helix
Research Institute (H.W.) Chiba 292-0812, Japan
Institute
of Life Science (A.Y.) Kurume University Kurume 839-0861,
Japan
The ß-casein promoter has been widely used to monitor the activation of STAT (signal transducer and activator of transcription)5 since STAT5 was originally found as a mediator of PRL-inducible ß-casein expression. However, not only is expression of the ß-casein gene regulated by STAT5 but it is also affected by other molecules such as glucocorticoid and Ras. In this report, we describe the transcriptional regulation of the ß-casein gene by cytokines in T cells. We have found that the ß-casein gene is expressed in a cytotoxic T cell line, CTLL-2, in response to interleukin-2 (IL-2), which activates STAT5. While IL-4 does not activate STAT5, it induces expression of STAT5-regulated genes in CTLL-2, i.e. ß-casein, a cytokine-inducible SH2-containing protein (CIS), and oncostatin M (OSM), suggesting that STAT6 activated by IL-4 substitutes for the function of STAT5 in T cells. IL-2-induced ß-casein expression was enhanced by dexamethasone, and this synergistic effect of Dexamethasone requires the sequence between -155 and -193 in the ß-casein promoter. Coincidentally, a deletion of this region enhanced the IL-2-induced expression of ß-casein. Expression of an active form of Ras, Ras(G12V), suppressed the IL-2-induced ß-casein and OSM gene expression, and the negative effect of Ras is mediated by the region between -105 and -193 in the ß-casein promoter. In apparent contradiction, expression of a dominant negative form of Ras, RasN17, also inhibited IL-2-induced activation of the promoter containing the minimal ß-casein STAT5 element as well as the promoters of CIS and OSM. In addition, Ras(G12V) complemented signaling by an erythropoietin receptor mutant defective in Ras activation and augmented the activation of the ß-casein promoter by the mutant erythropoietin receptor signaling, suggesting a possible role of Ras in Stat5-mediated gene expression. These results collectively reveal a complex interaction of STAT5 with other signaling pathways and illustrate that regulation of gene expression requires integration of opposing signals.
This article has been cited by other articles:
 |
|
 |
|
  S. Choi, X. Liu, P. Li, T. Akimoto, S. Y. Lee, M. Zhang, and Z. Yan Transcriptional profiling in mouse skeletal muscle following a single bout of voluntary running: evidence of increased cell proliferation J Appl Physiol, December 1, 2005; 99(6): 2406 - 2415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Necela and J. A. Cidlowski Mechanisms of Glucocorticoid Receptor Action in Noninflammatory and Inflammatory Cells Proceedings of the ATS, November 1, 2004; 1(3): 239 - 246. [Full Text] [PDF]
|
|
|
|
 |
|
 W. Ding, S. Bellusci, W. Shi, and D. Warburton Genomic structure and promoter characterization of the human Sprouty4 gene, a novel regulator of lung morphogenesis Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L52 - L59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sonoyama, I. Matsumura, S. Ezoe, Y. Satoh, X. Zhang, Y. Kataoka, E. Takai, M. Mizuki, T. Machii, H. Wakao, et al. Functional Cooperation among Ras, STAT5, and Phosphatidylinositol 3-Kinase Is Required for Full Oncogenic Activities of BCR/ABL in K562 Cells J. Biol. Chem., March 1, 2002; 277(10): 8076 - 8082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Doppler, M. Windegger, C. Soratroi, J. Tomasi, J. Lechner, S. Rusconi, A. C. B. Cato, T. Almlof, J. Liden, S. Okret, et al. Expression Level-Dependent Contribution of Glucocorticoid Receptor Domains for Functional Interaction with STAT5 Mol. Cell. Biol., May 1, 2001; 21(9): 3266 - 3279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Wyszomierski and J. M. Rosen Cooperative Effects of STAT5 (Signal Transducer and Activator of Transcription 5) and C/EBP {beta} (CCAAT/Enhancer-Binding Protein-{beta}) on {beta}-Casein Gene Transcription Are Mediated by the Glucocorticoid Receptor Mol. Endocrinol., February 1, 2001; 15(2): 228 - 240. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Mizuki, R. Fenski, H. Halfter, I. Matsumura, R. Schmidt, C. Muller, W. Gruning, K. Kratz-Albers, S. Serve, C. Steur, et al. Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways Blood, December 1, 2000; 96(12): 3907 - 3914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Peters, E. T. Maizels, M. C. Robertson, R. P.C. Shiu, M. S. Soloff, and M. Hunzicker-Dunn Induction of Relaxin Messenger RNA Expression in Response to Prolactin Receptor Activation Requires Protein Kinase C {delta} Signaling Mol. Endocrinol., April 1, 2000; 14(4): 576 - 590. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. S. Chapman, P. C. Lourenco, E. Tonner, D. J. Flint, S. Selbert, K. Takeda, S. Akira, A. R. Clarke, and C. J. Watson Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3 Genes & Dev., October 1, 1999; 13(19): 2604 - 2616. [Abstract] [Full Text]
|
|
|
|
|
|
K. Nakayama, T. Hara, M. Hibi, T. Hirano, and A. Miyajima A Novel Oncostatin M-inducible Gene OIG37 Forms a Gene Family with MyD118 and GADD45 and Negatively Regulates Cell Growth J. Biol. Chem., August 27, 1999; 274(35): 24766 - 24772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chida, O. Miura, A. Yoshimura, and A. Miyajima Role of Cytokine Signaling Molecules in Erythroid Differentiation of Mouse Fetal Liver Hematopoietic Cells: Functional Analysis of Signaling Molecules by Retrovirus-Mediated Expression Blood, March 1, 1999; 93(5): 1567 - 1578. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
